Literature DB >> 22153200

Access to data in industry-sponsored trials.

Andreas Lundh1, Lasse T Krogsbøll2, Peter C Gøtzsche3.   

Abstract

Mesh：

Year:  2011        PMID： 22153200     DOI： 10.1016/S0140-6736(11)61871-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

2.  SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krle A-Jerić; Asbjørn Hrobjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Dore; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Rev Panam Salud Publica       Date:  2015-12

3.  Redactions in protocols for drug trials: what industry sponsors concealed.

Authors:  Mikkel Marquardsen; Michelle Ogden; Peter C Gøtzsche
Journal:  J R Soc Med       Date:  2018-01-25       Impact factor: 5.344

4.  SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Doré; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

5.  A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one.

Authors:  Nisha Venugopal; Gayatri Saberwal
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

6.  Sharing of clinical trial data among trialists: a cross sectional survey.

Authors:  Vinay Rathi; Kristina Dzara; Cary P Gross; Iain Hrynaszkiewicz; Steven Joffe; Harlan M Krumholz; Kelly M Strait; Joseph S Ross
Journal:  BMJ       Date:  2012-11-20

7.  Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study.

Authors:  Emma Maund; Britta Tendal; Asbjørn Hróbjartsson; Andreas Lundh; Peter C Gøtzsche
Journal:  BMJ       Date:  2014-06-04

8.  Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey.

Authors:  Vinay K Rathi; Kelly M Strait; Cary P Gross; Iain Hrynaszkiewicz; Steven Joffe; Harlan M Krumholz; Kristina Dzara; Joseph S Ross
Journal:  Trials       Date:  2014-10-02       Impact factor: 2.279

9.  Sponsors' participation in conduct and reporting of industry trials: a descriptive study.

Authors:  Andreas Lundh; Lasse T Krogsbøll; Peter C Gøtzsche
Journal:  Trials       Date:  2012-08-24       Impact factor: 2.279

10.  Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translational.

Authors:  Pauline McCormack; Simon Woods; Annemieke Aartsma-Rus; Lynn Hagger; Agnes Herczegfalvi; Emma Heslop; Joseph Irwin; Janbernd Kirschner; Patrick Moeschen; Francesco Muntoni; Marie-Christine Ouillade; Jes Rahbek; Christoph Rehmann-Sutter; Francoise Rouault; Thomas Sejersen; Elizabeth Vroom; Volker Straub; Kate Bushby; Alessandra Ferlini
Journal:  PLoS Curr       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.